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A century of trends in adult human height
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Abstract Being taller is associated with enhanced longevity, and higher education and earnings.
We reanalysed 1472 population-based studies, with measurement of height on more than 18.6
million participants to estimate mean height for people born between 1896 and 1996 in 200
countries. The largest gain in adult height over the past century has occurred in South Korean
women and Iranian men, who became 20.2 cm (95% credible interval 17.5–22.7) and 16.5 cm (13.3–
19.7) taller, respectively. In contrast, there was little change in adult height in some sub-Saharan
African countries and in South Asia over the century of analysis. The tallest people over these 100
years are men born in the Netherlands in the last quarter of 20th century, whose average heights
surpassed 182.5 cm, and the shortest were women born in Guatemala in 1896 (140.3 cm; 135.8–
144.8). The height differential between the tallest and shortest populations was 19-20 cm a century
ago, and has remained the same for women and increased for men a century later despite
substantial changes in the ranking of countries.
DOI: 10.7554/eLife.13410.001
Introduction
Being taller is associated with enhanced longevity, lower risk of adverse pregnancy outcomes and
cardiovascular and respiratory diseases, and higher risk of some cancers (Paajanen et al., 2010;
Emerging Risk Factors Collaboration, 2012; Green et al., 2011; Nelson et al., 2015; Batty et al.,
2010; World Cancer Research Fund / American Institute for Cancer Research, 2007;
2010; 2011; 2012; 2014a; 2014b; Nu¨esch et al., 2015; Davies et al., 2015; Zhang et al., 2015;
Kozuki et al., 2015; Black et al., 2008). There is also evidence that taller people on average have
higher education, earnings, and possibly even social position (Adair et al., 2013; Stulp et al., 2015;
Barker et al., 2005; Strauss and Thomas, 1998; Chen and Zhou, 2007; Case and Paxson, 2008).
Although height is one of the most heritable human traits (Fisher, 1919; Lettre, 2011), cross-
population differences are believed to be related to non-genetic, environmental factors. Of these,
foetal growth (itself related to maternal size, nutrition and environmental exposures), and nutrition
and infections during childhood and adolescence are particularly important determinants of height
during adulthood (Cole, 2000; Silventoinen et al., 2000; Dubois et al., 2012; Haeffner et al.,
2002; Sørensen et al., 1999; Victora et al., 2008; Eveleth and Tanner, 1990; Tanner, 1962; Tan-
ner, 1992; Bogin, 2013). Information on height, and its trends, can therefore help understand the
health impacts of childhood and adolescent nutrition and environment, and of their social, economic,
and political determinants, on both non-communicable diseases (NCDs) and on neonatal health and
survival in the next generation (Cole, 2000; Tanner, 1992; Tanner, 1987).
Trends in men’s height have been analysed in Europe, the USA, and Japan for up to 250 years,
using data on conscripts, voluntary military personnel, convicts, or slaves (Cole, 2000; Floud et al.,
1990; Fogel et al., 1983; Schmidt et al., 1995; Floud et al., 2011; Tanner et al., 1982;
Hatton and Bray, 2010; Tanner, 1981; Facchini and Gualdi-Russo, 1982). There are fewer histori-
cal data for women, and for other regions where focus has largely been on children and where adult
data tend to be reported at one point in time or over short periods (Subramanian et al., 2011;
Grasgruber et al., 2014; Baten and Blum, 2012; Deaton, 2007; Mamidi et al., 2011; van Zanden
et al., 2014). In this paper, we pooled worldwide population-based data to estimate height in adult-
hood for men and women born over a whole century throughout the world.
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Results
We estimated that people born in 1896 were shortest in Asia and in Central and Andean Latin
America (Figure 1 and Figure 2). The 1896 male birth cohort on average measured only 152.9
cm (credible interval 147.9–157.9) in Laos, which is the same as a well-nourished 12.5-year boy
according to international growth standards (de Onis et al., 2007), followed by Timor-Leste and
Guatemala. Women born in the same year in Guatemala were on average 140.3 cm (135.8–
144.8), the same as a well-nourished 10-year girl. El Salvador, Peru, Bangladesh, South Korea and
Japan had the next shortest women. The tallest populations a century ago lived in Central and
Northern Europe, North America and some Pacific islands. The height of men born in Sweden,
Norway and the USA surpassed 171 cm, ~18–19 cm taller than men in Laos. Swedish women,
with average adult height of 160.3 cm (158.2–162.4), were the tallest a century ago and 20 cm
taller than women in Guatemala. Women were also taller than 158 cm in Norway, Iceland, the
USA and American Samoa.
Changes in adult height over the century of analysis varied drastically across countries. Notably,
although the large increases in European men’s heights in the 19th and 20th century have been
highlighted, we found that the largest gains since the 1896 birth cohort occurred in South Korean
women and Iranian men, who became 20.2 cm (17.5–22.7) and 16.5 cm (13.3–19.7) taller, respec-
tively (Figure 3, Figure 4 and Figure 5). As a result, South Korean women moved from the fifth
shortest to the top tertile of tallest women in the world over the course of a century. Men in South
Korea also had large gains relative to other countries, by 15.2 cm (12.3–18.1). There were also large
gains in height in Japan, Greenland, some countries in Southern Europe (e.g., Greece) and Central
Europe (e.g., Serbia and Poland, and for women Czech Republic). In contrast, there was little gain in
height in many countries in sub-Saharan Africa and South Asia.
The pace of growth in height has not been uniform over the past century. The impressive rise in
height in Japan stopped in people born after the early 1960s (Figure 6). In South Korea, the flatten-
ing began in the cohorts born in the 1980s for men and it may have just begun in women. As a
result, South Korean men and women are now taller than their Japanese counterparts. The rise is
eLife digest People from different countries grow to different heights. This may be partly due
to genetics, but most differences in height between countries have other causes. For example,
children and adolescents who are malnourished, or who suffer from serious diseases, will generally
be shorter as adults. This is important because taller people generally live longer, are less likely to
suffer from heart disease and stroke, and taller women and their children are less likely to have
complications during and after birth. Taller people may also earn more and be more successful at
school. However, they are also more likely to develop some cancers.
The NCD Risk Factor Collaboration set out to find out how tall people are, on average, in every
country in the world at the moment, and how this has changed over the past 100 years. The analysis
revealed large differences in height between countries. The tallest men were born in the last part of
the 20th century in the Netherlands, and were nearly 183 cm tall on average. The shortest women
were born in 1896 in Guatemala, and were on average 140 cm tall. The difference between the
shortest and tallest countries is about 20 cm for both men and women. This means there are large
differences between countries in terms of nutrition and the risk of developing some diseases.
The way in which height has changed over the past 100 years also varies from country to country.
Iranian men born in 1996 were around 17 cm taller than those born in 1896, and South Korean
women were 20 cm taller. In other parts of the world, particularly in South Asia and parts of Africa,
people are only slightly taller than 100 years ago, and in some countries people are shorter than
they were 50 years ago.
There is a need to better understand why height has changed in different countries by different
amounts, and use this information to improve nutrition and health across the world. It would also be
valuable to understand how much becoming taller has been responsible for improved health and
longevity throughout the world.
DOI: 10.7554/eLife.13410.002
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continuing in other East and Southeast Asian countries like China and Thailand, with Chinese men
and women having surpassed the Japanese (but not yet as tall as South Koreans). The rise in adult
Figure 1. Adult height for the 1896 and 1996 birth cohorts for men. See www.ncdrisc.org for interactive version.
DOI: 10.7554/eLife.13410.003
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height also seems to have plateaued in South Asian countries like Bangladesh and India at much
lower levels than in East Asia, e.g., 5–10 cm shorter than it did in Japan and South Korea.
Figure 2. Adult height for the 1896 and 1996 birth cohorts for women. See www.ncdrisc.org for interactive version.
DOI: 10.7554/eLife.13410.004
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There were also variations in the time course of height change across high-income western coun-
tries, with height increase having plateaued in Northern European countries like Finland and in
Figure 3. Change in adult height between the 1896 and 1996 birth cohorts.
DOI: 10.7554/eLife.13410.005
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Figure 4. Height in adulthood for the 1896 and 1996 birth cohorts for men. The open circle shows the adult height
attained by the 1896 birth cohort and the filled circle that of the 1996 birth cohort; the length of the connecting
Figure 4 continued on next page
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English-speaking countries like the UK for 2–3 decades (Larnkaer et al., 2006; Scho¨nbeck et al.,
2013), followed by Eastern Europe (Figure 7). The earliest of these occurred in the USA, which was
one of the tallest nations a century ago but has now fallen behind its European counterparts after
having had the smallest gain in height of any high-income country (Tanner, 1981; Komlos and Lau-
derdale, 2007; Komlos and Baur, 2004; Sokoloff and Villaflor, 1982). In contrast, height is still
increasing in some Southern European countries (e.g., Spain), and in many countries in Latin
America.
As an exception to the steady gains in most countries, adult height decreased or at best
remained the same in many countries in sub-Saharan Africa for cohorts born after the early 1960s, by
around 5 cm from its peak in some countries (see for example Niger, Rwanda, Sierra Leone, and
Uganda in Figure 8). More recently, the same seems to have happened for men, but not women, in
some countries in Central Asia (e.g., Azerbaijan and Uzbekistan) and Middle East and North Africa
(e.g., Egypt and Yemen), whereas in others (e.g., Iran) both sexes continue to grow taller.
Men born in 1996 surpass average heights of 181 cm in the Netherlands, Belgium, Estonia, Latvia
and Denmark, with Dutch men, at 182.5 cm (180.6–184.5), the tallest people on the planet. The gap
with the shortest countries – Timor-Leste, Yemen and Laos, where men are only ~160 cm tall – is 22–
23 cm, an increase of ~4 cm on the global gap in the 1896 birth cohort. Australia was the only non-
European country where men born in 1996 were among the 25 tallest in the world. Women born in
1996 are shortest in Guatemala, with an average height of 149.4 cm (148.0–150.8), and are shorter
than 151 cm in the Philippines, Bangladesh and Nepal. The tallest women live in Latvia, the Nether-
lands, Estonia and Czech Republic, with average height surpassing 168 cm, creating a 20 cm global
gap in women’s height (Figure 5).
Male and female heights were correlated across countries in 1896 as well as in 1996. Men were
taller than women in every country, on average by ~11 cm in the 1896 birth cohort and ~12 cm in
the 1996 birth cohort (Figure 9). In the 1896 birth cohort, the male-female height gap in countries
where average height was low was slightly larger than in taller nations. In other words, at the turn of
the 20th century, men seem to have had a relative advantage over women in undernourished com-
pared to better-nourished populations. A century later, the male-female height gap is about the
same throughout the height range. Changes in male and female heights over the century of analysis
were also correlated, which is in contrast to low correlation between changes in male and female
BMIs as reported elsewhere (NCD Risk Factor Collaboration, 2016).
Change in population mean height was not correlated with change in mean BMI (NCD Risk Fac-
tor Collaboration, 2016) across countries for men (correlation coefficient =  0.016) and was weakly
inversely correlated for women (correlation coefficient =  0.28) (Figure 10). Countries like Japan,
Singapore and France had larger-than-median gains in height but little change in BMI, in contrast to
places like the USA and Kiribati where height has increased less than the worldwide median while
BMI has increased a great deal.
Discussion
We found that over the past century adult height has changed substantially and unevenly in the
world’s countries, with no indication of convergence across countries. The height differential
between the tallest and shortest populations was ~19 cm for men and ~20 cm for women a century
ago, and has remained about the same for women and increased for men a century later despite
substantial changes in the ranking of countries in terms of adult height.
Data from military conscripts and personnel have allowed reconstructing long-term trends in
height in some European countries and the USA, albeit largely for men, and treating it as a ’mirror’
to social and environmental conditions that affect nutrition, health and economic prosperity, in each
generation and across generations (Tanner, 1987; Fogel, 2004; Komlos, 2009; Martins et al.,
2014; Martorell, 1995). Our results on the large gains in continental European countries, and that
Figure 4 continued
line represents the change in height over the century of analysis. The numbers next to each circle show the
country’s rank in terms of adult height for the corresponding cohort. See www.ncdrisc.org for interactive version.
DOI: 10.7554/eLife.13410.006
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Figure 5. Height in adulthood for the 1896 and 1996 birth cohorts for women. The open circle shows the adult
height attained by the 1896 birth cohort and the filled circle that of the 1996 birth cohort; the length of the
Figure 5 continued on next page
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they have overtaken English-speaking countries like the USA, are consistent with these earlier studies
although these earlier analyses covered fewer countries in Eastern and Southern Europe, and used
some self-reported data with simple adjustments that cannot fully correct for their bias (Hatton and
Bray, 2010; Facchini and Gualdi-Russo, 1982; Baten and Blum, 2012).
Less has been known about trends in women’s height, and those in non-English-speaking/non-
European parts of the world. We found that some of the most important changes in height have
happened in these under-investigated populations. In particular, South Korean and Japanese men
and women, and Iranian men, have had larger gains than European men, and similar trends are now
happening in China and Thailand. These gains may partially account for the fact that women in Japan
and South Korea have achieved the first and fourth highest life expectancy in the world (see also
below). In contrast to East Asia’s impressive gains, the rise in height seems to have stopped early in
South Asia and reversed in Africa, reversing or diminishing Africa’s earlier advantage over Asia. Prior
Figure 5 continued
connecting line represents the change in height over the century of analysis. The numbers next to each circle show
the country’s rank in terms of adult height for the corresponding cohort. See www.ncdrisc.org for interactive
version.
DOI: 10.7554/eLife.13410.007
Japan
H
e
ig
h
t 
(c
m
)
1
3
0
1
4
0
1
5
0
1
6
0
1
7
0
1
8
0
1
9
0
●
●
●
●
●
National
Sub!national
Community
Rural
Urban
Mixed
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●●●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
South Korea
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
China
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
● ●
●
●
●
●
●●
●
●
●●
●
●
●
●
●
●
●
●
●●●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
● ●●●
●
● ●●
●
●
●
●
●●
●
●
●
●●●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
Thailand
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●●●
●
●●
●
●
●
●
●
●
●
●
●
●
Bangladesh
●●
●●●
●
●
●
●
India
●
●
●
●
●
●
●
●●
●
●●
●●●●
● ●
●
●
●
●
●●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●●
●
●
●●
●
●
●
●
        Men
Japan
H
e
ig
h
t 
(c
m
)
1
3
0
1
4
0
1
5
0
1
6
0
1
7
0
1
8
0
1
9
0
1896 1916 1936 1956 1976 1996
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
● ●●
●
●
●
South Korea
1896 1916 1936 1956 1976 1996
●
●●
●
●
●
●
●
●
●●●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
China
1896 1916 1936 1956 1976 1996
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●●
●
●
●
●
● ●●
●●
●
●●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●●●
●
●
●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●●
●
● ●●
●
●
● ●
●
●●●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
●
●●●●
●
●
●
●
●
●
●
●●●
●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
Thailand
1896 1916 1936 1956 1976 1996
●●●●●
●
●
●
●
●
●
●
●
●●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●●●
●●●
●●
●
●
●
●
●
●
●
●
●
●
Bangladesh
1896 1916 1936 1956 1976 1996
●
●●●
●
●
●●●● ●●
●●● ●●
●
●●●●●
●
●
●
●
India
1896 1916 1936 1956 1976 1996
●●
●●● ●●
●
●
●
●
●
●●
●
●
●
●●●●●
●●●
●●
●
●
●
●
●●
●
●
●●●
●
●
●●●
●
●
●●
●●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●
●●
       Women
       Birth cohort
Figure 6. Trends in height for the adult populations of selected countries in Asia. The solid line represents the posterior mean and the shaded area the
95% credible interval of the estimates. The points show the actual data from each country, together with its 95% confidence interval due to sampling.
The solid line and shaded area show estimated height at 18 years of age, while the data points show height at the actual age of measurement. The
divergence between estimates and data for earlier birth cohorts is because participants from these birth cohorts were generally older when their
heights were measured.
DOI: 10.7554/eLife.13410.008
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studies have documented a rise in stunting in children in sub-Saharan Africa which continued to the
mid-1990s (Stevens et al., 2012). Our results indicate that such childhood adversity may have car-
ried forward to adulthood and be affecting health in the region. The early African advantage over
Asia may also have been partly due to having a more diverse diet compared to the vegetable and
cereal diet in Asia, partly facilitated by lower population density (Deaton, 2007; Moradi, 2010). Ris-
ing population, coupled with worsening economic status during structural adjustment, may have
undermined earlier dietary advantage (Stevens et al., 2012; Pongou et al., 2006; Weil et al., 1990;
Sundberg, 2009).
The main strengths of our study are its novel scope of estimating a century of trends in adult
height for all countries in the world and for both sexes. Our population-based results complement
the individual-level studies on the genetic and environmental determinants of within-population vari-
ation in height, and will help develop and test hypotheses about the determinants of adult height,
and its health consequences. We achieved this by using a large number of population-based data
sources from all regions of the world. We put particular emphasis on data quality and used only pop-
ulation-based data that had measured height, which avoids bias in self-reported height. Data were
analysed according to a common protocol before being pooled, and characteristics and quality of
data sources were verified through repeated checks by Collaborating Group members. Finally, we
pooled data using a statistical model that could characterize non-linear trends and that used all avail-
able data while giving more weight to national data than to subnational and community surveys.
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Figure 7. Trends in height for the adult populations of selected countries in Europe. The solid line represents the posterior mean and the shaded area
the 95% credible interval of the estimates. The points show the actual data from each country, together with its 95% confidence interval due to
sampling. The solid line and shaded area show estimated height at 18 years of age, while the data points show height at the actual age of
measurement. The divergence between estimates and data for earlier birth cohorts is because participants from these birth cohorts were generally
older when their heights were measured.
DOI: 10.7554/eLife.13410.009
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Although we have gathered an unprecedentedly comprehensive database of human height and
growth, and have applied a statistical model that maximally utilizes the information in these sources,
data in some countries were rather limited or were from community or sub-national studies. This is
reflected in larger uncertainty of the estimated height in these countries. To overcome this, surveil-
lance of growth, which has focused largely on children, should also systematically monitor adoles-
cents and adults given the increasingly abundant evidence on their effects on adult health and
human capital. Even measured height data can be subject to measurement error depending on how
closely study protocols are followed. Finally, we did not have separate data on leg and trunk lengths,
which may differ in their determinants, especially in relation to age at menarche and pre- vs. post-
pubertal growth and nutrition, and health effects (Tanner et al., 1982; Frisch and Revelle, 1971).
Greater height in adulthood is both beneficially (cardiovascular and respiratory diseases) and
harmfully (colorectal, postmenopausal breast and ovarian cancers, and possibly pancreatic, prostate
and premenopausal breast cancers) associated with several diseases, independently of its inverse
correlation with BMI (Paajanen et al., 2010; Emerging Risk Factors Collaboration, 2012;
Green et al., 2011; Nelson et al., 2015; Batty et al., 2010; World Cancer Research Fund / Ameri-
can Institute for Cancer Research, 2007; 2010; 2011; 2012; 2014a; 2014b; Nu¨esch et al., 2015;
Davies et al., 2015; Zhang et al., 2015). If the associations in epidemiological studies are causal,
which is supported by the more recent evidence from Mendelian randomisation studies
(Green et al., 2011; Nu¨esch et al., 2015; Davies et al., 2015; Zhang et al., 2015), the ~20 cm
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Figure 8. Trends in height for the adult populations of selected countries in the Middle East, North Africa, and sub-Saharan Africa. The solid line
represents the posterior mean and the shaded area the 95% credible interval of the estimates. The points show the actual data from each country,
together with its 95% confidence interval due to sampling. The solid line and shaded area show estimated height at 18 years of age, while the data
points show height at the actual age of measurement. The divergence between estimates and data for earlier birth cohorts is because participants from
these birth cohorts were generally older when their heights were measured.
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height range in the world is associated with a 17% lower risk of cardiovascular mortality and 20–40%
higher risk of various site-specific cancers, in tall versus short countries. Consistent with individual-
level evidence on the association between taller height and lower all-cause mortality in adult ages
(Emerging Risk Factors Collaboration, 2012), gains in mean population height in successive
cohorts are associated with lower mortality in middle and older ages in countries with reliable mor-
tality data (correlation coefficient =  0.58 for men and  0.68 for women) (Figure 11), demonstrat-
ing the large impacts of height gain on population health and longevity. Further, short maternal
stature increases the risk of small-for-gestational-age and preterm births, both risk factors for neona-
tal mortality, and of pregnancy complications (Kozuki et al., 2015; Black et al., 2008). Therefore,
improvements vs. stagnation in women’s height can influence trends in infant and maternal
mortality.
Our study also shows the potential for using height in early adulthood as an indicator that integra-
tes across different dimensions of sustainable human development. Adult height signifies not only
foetal and early childhood nutrition, which was included in the Millennium Development Goals, but
also that of adolescents (Lancet, 2014). Further, adult height is a link between these early-life expe-
riences and NCDs, longevity, education and earnings. It can easily be measured in health surveys
and can be used to investigate differences across countries and trends over time, as done in our
work, as well as within-country inequalities. Therefore, height in early adulthood, which varies sub-
stantially across countries and over time, provides a measurable indicator for sustainable develop-
ment, with links to health and longevity, nutrition, education and economic productivity.
Materials and methods
Overview
We estimated trends in mean height for adults born from 1896 to 1996 (i.e., people who had
reached their 18th birthday from 1914 to 2014) in 200 countries and territories. Countries were orga-
nized into 20 regions, mostly based on a combination of geography and national income
(Supplementary file 1). Our study had two steps, described below. First, we identified, accessed,
and re-analysed population-based measurement studies of human anthropometry. We then used a
statistical model to estimate trends for all countries and territories.
Data sources
We used data sources that were representative of a national, subnational, or community population
and had measured height. We did not use self-reported height because it is subject to systematic
bias that varies by geography, time, age, sex, and socioeconomic characteristics like education and
ethnicity (Engstrom et al., 2003; Connor Gorber et al., 2007; Wetmore and Mokdad, 2012;
Schenker et al., 2010; Ezzati et al., 2006; Clarke et al., 2014; Hayes et al., 2011).
Figure 9. Height in adulthood for men vs. women for the 1896 and 1996 birth cohorts, and change in men’s vs. women’s heights from 1896 to 1996.
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Data sources were included in the NCD-RisC database if:
. measured data on height, weight, waist circumference, or hip circumference were available;
. study participants were five years of age and older;
. data were collected using a probabilistic sampling method with a defined sampling frame;
. data were representative of the general population at the national, subnational, or community
level;
. data were from the countries and territories listed in Supplementary file 1.
We excluded data sources on population subgroups whose anthropometric status may differ sys-
tematically from the general population, including:
. studies that had included or excluded people based on their health status or cardiovascular
risk;
. ethnic minorities;
. specific educational, occupational, or socioeconomic subgroups of the population; and
. those recruited through health facilities, with the exception noted below.
We used school-based data in countries where secondary school enrolment was 70% or higher,
and used data whose sampling frame was health insurance schemes in countries where at least 80%
of the population were insured. We used data collected through general practice and primary care
clinics in high-income countries with universal insurance, because contact with the primary care sys-
tems tends to be at least as good as response rates for population-based surveys. No studies were
excluded based on the level of height.
We used multiple routes for identifying and accessing data. We accessed publicly available popu-
lation-based multi-country and national measurement surveys (e.g., Demographic and Health Sur-
veys, and surveys identified via the Inter-University Consortium for Political and Social Research and
European Health Interview & Health Examination Surveys Database) as well as the World Health
Organization (WHO) STEPwise approach to Surveillance (STEPS) surveys. We requested identifica-
tion and access to population-based data sources from ministries of health and other national health
agencies, via WHO and its regional offices. Requests were also sent via the World Heart Federation
Figure 10. Change, over the 1928–1967 birth cohorts, in mean BMI vs. in mean height. Each point shows one country. BMI change was calculated for
mean BMI at 45–49 years of age – an age when diseases associated with excess weight become common but weight loss due to pre-existing disease is
still uncommon. BMI data were available for 1975–2014 (NCD Risk Factor Collaboration, 2016); 45–49 year olds in these years correspond to 1928–
1967 birth cohorts. BMI data were from a pooled analysis of 1698 population-based measurement studies with 19.2 million participants, with details
reported elsewhere (NCD Risk Factor Collaboration, 2016).
DOI: 10.7554/eLife.13410.012
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to its national partners. We made a similar request to the NCD Risk Factor Collaboration (NCD-RisC;
www.ncdrisc.org), a worldwide network of health researchers and practitioners working on NCD risk
factors.
To identify major sources not accessed through the above routes, we searched and reviewed
published studies. Specifically, we searched Medline (via PubMed) for articles published between 1st
January 1950 and 12th March 2013 using the search terms ’body size’[mh:noexp] OR ’body
height’[mh:noexp] OR ’body weight’[mh:noexp] OR ’birth weight’[mh:noexp] OR ’overweight’[mh:
noexp] OR ’obesity’[mh] OR ’thinness’[mh:noexp] OR ’Waist-Hip Ratio’[mh:noexp] or ’Waist Circum-
ference’[mh:noexp] or ’body mass index’ [mh:noexp]) AND (’Humans’[mh]) AND(’1950’[PDAT]:
’2013’[PDAT]) AND (’Health Surveys’[mh] OR ’Epidemiological Monitoring’[mh] OR ’Prevalence’[mh])
NOT Comment[ptyp] NOT Case Reports[ptyp].
Articles were screened according to the inclusion and exclusion criteria described above. The
number of articles identified and retained is summarised in Supplementary file 2. As described
above, we contacted the corresponding authors of all eligible studies and invited them to join NCD-
RisC. We did similar searches for other cardio-metabolic risk factors including blood pressure, serum
cholesterol, and blood glucose. All eligible studies were invited to join NCD-RisC and were
requested to analyse data on all cardio-metabolic risk factors.
Anonymised individual record data from sources included in NCD-RisC were re-analysed by the
Pooled Analysis and Writing Group or by data holders according to a common protocol. All re-ana-
lysed data sources included mean height in standard age groups (18 years, 19 years, 20–29 years,
followed by 10 year age groups and 80+ years), as well as sample sizes and standard errors. All
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Figure 11. Association between change in probability of dying from any cause between 50 and 70 years of age and change in adult height by country
for cohorts born between 1898 and 1946. Probability of death was calculated using a cohort life table. Mortality data were available for 1950 to 2013.
The 1898 birth cohort is the first cohort whose mortality experience at 50–54 years of age was seen in the data, and the 1946 birth cohort the last cohort
whose mortality experience at 65–69 years of age was seen in the data. The dotted line shows the linear association. The 62 countries included have
vital registration that is >80% complete and have data on all-cause mortality for at least 30 cohorts. The countries are Argentina, Australia, Austria,
Azerbaijan, Belarus, Belgium, Belize, Brazil, Bulgaria, Canada, Chile, China (Hong Kong SAR), Colombia, Costa Rica, Croatia, Cuba, Czech Republic,
Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hungary, Iceland, Ireland, Israel, Italy, Japan, Kazakhstan, Kyrgyzstan, Latvia,
Lithuania, Luxembourg, Macedonia (TFYR), Malta, Mauritius, Mexico, Moldova, Netherlands, New Zealand, Norway, Poland, Portugal, Puerto Rico,
Romania, Russian Federation, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, Trinidad and Tobago, Turkmenistan, Ukraine, United
Kingdom, United States of America, Uruguay, Uzbekistan and Venezuela.
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analyses incorporated appropriate sample weights and complex survey design when applicable. To
ensure summaries were prepared according to the study protocol, the Pooled Analysis and Writing
Group provided computer code to NCD-RisC members who requested assistance. We also recorded
information about the study population, period of measurement and sampling approach. This infor-
mation was used to establish that each data source was population-based, and to assess whether it
covered the whole country, multiple subnational regions, or one or a small number of communities,
and whether it was rural, urban, or combined. All submitted data were checked by at least two inde-
pendent members of the Pooled Analysis and Writing Group to ensure that their sample selection
met the inclusion criteria and that height was measured and not self-reported. Questions and clarifi-
cations about sample design and measurement method were discussed with the Collaborating
Group members and resolved before data were incorporated in the database. We also extracted
data from additional national health surveys, one subnational STEPS survey, and six MONICA sites
from published reports.
We identified duplicate data sources by comparing studies from the same country and year.
Additionally, NCD-RisC members received the list of all data sources in the database and were
asked to ensure that the included data from their country met the inclusion criteria and that there
were no duplicates. Data sources used in our analysis are listed in Supplementary file 3.
In this paper, we used data on height in adulthood (18 years of age and older) from the NCD-
RisC database for participants born between 1896 and 1996. We used 1472 population-based data
sources with measurements on over 18.6 million adults born between 1896 and 1996 whose height
had been measured. We did not use data from the 1860–1895 cohorts because data on these early
cohorts were available for only six countries (American Samoa, India, Japan, Norway, Switzerland
and USA). We had data for 179 of the 200 countries for which estimates were made; these 179 coun-
tries covered 97% of the world’s population. All countries had some data on people born after 1946
(second half of analysis period); 134 had data on people born between 1921 and 1945; and 72 had
data on people born in 1920 or earlier. Across regions, there were between an average of 2.0 data
sources per country in the Caribbean to 34 sources per country in high-income Asia Pacific. 1108
sources had data on men as well as women, 153 only on men, and 211 only on women.
Statistical methods
The statistical method is described in detail elsewhere (Danaei et al., 2011; Finucane et al., 2014).
In summary, the model had a hierarchical structure in which estimates of mean height for each coun-
try and year were nested in regional levels and trends, which were in turn nested in those of super-
regions and worldwide. In this structure, estimates of mean height for each country and year were
informed by its own data, if available, and by data from other years in the same country and in other
countries, especially those in the same region with data for similar time periods. The hierarchical
structure shares information to a greater degree when data are non-existent or weakly informative
(e.g., because they have a small sample size), and to a lesser extent in data-rich countries and
regions.
We used birth cohort as the time scale of analysis. We calculated the birth cohort for each obser-
vation by subtracting the mid-age of its age group from the year in which data were collected. We
modelled trends in height by birth cohort as a combination of linear and non-linear trends, both with
a hierarchical structure; the non-linear trend was specified using a second-order random walk
(Rue and Held, 2005). The model also included a term that allowed each birth cohort’s height to
change as it aged, e.g., because there is gradual loss of height during ageing and because as a
cohort ages those who survive may be taller. The model described by Finucane et al
(Finucane et al., 2014) had used a cubic spline for age associations of risk factor levels. In practice,
the estimated change in population mean height over age was linear with a small slope of over 0.2
cm shorter for men and 0.3 cm shorter for women with each decade of older age. Therefore, we
used a linear specification for computational efficiency.
While all our data were from samples of the general population, 796 (54%) of data sources repre-
sented national populations, another 199 (14%) major sub-national regions (e.g., one or more provin-
ces or regions of a country), and the remaining 477 (32%) one or a small number of communities.
The model accounted for the fact that sub-national and community studies, while informative, might
systematically differ from nationally representative ones, and also have larger variation relative to
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the true values than national studies (e.g., see data from China, India, Japan and the UK in Figure 6
and Figure 7).
We fitted the Bayesian model with the Markov chain Monte Carlo (MCMC) algorithm. We moni-
tored mixing and convergence using trace plots and Brooks–Gelman–Rubin diagnostics (Brooks and
Gelman, 1998). We obtained 5000 post burn-in samples from the posterior distribution of model
parameters, used to obtain the posterior distribution of mean height. The reported credible intervals
represent the 2.5th–97.5th percentiles of the posterior distribution. We report mean height at age
18 years for each birth cohort; heights at other ages are available from the authors. All analyses
were done separately by sex because height and its trends over time may differ between men and
women.
We tested how well our statistical model predicts missing values by removing data from 10% of
countries with data (i.e., created the appearance of countries with no data where we actually had
data). The countries whose data were withheld were randomly selected from the following three
groups: data-rich (more than 25 cohorts of data, with at least five cohorts after 1960), data-poor (up
to and including 12 cohorts of data for women and 8 cohorts for men), and average data availability
(13 to 25 cohorts for women, 9 to 25 cohorts for men, or more than 25 cohorts in total with fewer
than five after 1960). In total, there were 64 data-rich countries for women and 51 for men; 57 data-
poor countries for women and 58 for men; and 56 countries for women and 60 for men that had
average data availability. We fitted the model to the data from the remaining 90% of countries and
made estimates of the held-out observations. We repeated the test five times, holding out a differ-
ent subset of data in each repetition. We calculated the differences between the held-out data and
the estimates. We also checked the 95% credible intervals of the estimates; in a model with good
external predictive validity, 95% of held-out values would be included in the 95% credible intervals.
Our model performed extremely well; specifically, the estimates of mean height were unbiased as
evidenced with median errors that were very close to zero globally, and less than ±0.2 cm in every
subset of withheld data (Supplementary file 4). Even the 25th and 75th percentiles of errors rarely
exceeded ±1 cm. Median absolute error was only about 0.5 cm, and did not exceed 1.0 cm in sub-
sets of withheld data. The 95% credible intervals of estimated mean heights covered 97% of true
data for both men and women, which implies good estimation of uncertainty; among subgroups of
data, coverage was never < 90%.
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Escobedo-de la Pen˜a (Instituto Mexicano del Seguro Social, Mexico)*; Alun Evans (The Queen’s Uni-
versity of Belfast, UK)*; David Faeh (University of Zurich, Switzerland)*; Caroline H Fall (University of
Southampton, UK)*; Farshad Farzadfar (Tehran University of Medical Sciences, Iran)*; Francisco J
Felix-Redondo (Centro de Salud Villanueva Norte, Spain)*; Trevor S Ferguson (The University of the
West Indies, Jamaica)*; Daniel Ferna´ndez-Berge´s (Hospital Don Benito-Villanueva de la Serena,
Spain)*; Daniel Ferrante (Ministry of Health, Argentina)*; Marika Ferrari (Council for Agricultural
Research and Economics, Italy)*; Catterina Ferreccio (Pontificia Universidad Cato´lica de Chile, Chile)
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*; Jean Ferrieres (Toulouse University School of Medicine, France)*; Joseph D Finn (University of
Manchester, UK)*; Krista Fischer (University of Tartu, Estonia)*; Eric Monterubio Flores (Instituto
Nacional de Salud Pu´blica, Mexico)*; Bernhard Fo¨ger (Agency for Preventive and Social Medicine,
Austria)*; Leng Huat Foo (Universiti Sains Malaysia, Malaysia)*; Ann-Sofie Forslund (Lulea˚ University,
Sweden)*; Maria Forsner (Dalarna University, Sweden)*; Stephen P Fortmann (Stanford University,
USA)*; Heba M Fouad (World Health Organization Regional Office for the Eastern Mediterranean,
Egypt)*; Damian K Francis (The University of the West Indies, Jamaica)*; Maria do Carmo Franco
(Federal University of Sa˜o Paulo, Brazil)*; Oscar H Franco (Erasmus Medical Center Rotterdam, The
Netherlands)*; Guillermo Frontera (Hospital Universitario Son Espases, Spain)*; Flavio D Fuchs (Hos-
pital de Clinicas de Porto Alegre, Brazil)*; Sandra C Fuchs (Universidade Federal do Rio Grande do
Sul, Brazil)*; Yuki Fujita (Kindai University Faculty of Medicine, Japan)*; Takuro Furusawa (Kyoto Uni-
versity, Japan)*; Zbigniew Gaciong (Medical University of Warsaw, Poland)*; Mihai Gafencu (Victor
Babes University of Medicine and Pharmacy Timisoara, Romania)*; Dickman Gareta (University of
KwaZulu-Natal, South Africa)*; Sarah P Garnett (University of Sydney, Australia)*; Jean-Michel Gas-
poz (Geneva University Hospitals, Switzerland)*; Magda Gasull (CIBER en Epidemiologı´a y Salud
Pu´blica, Spain)*; Louise Gates (Australian Bureau of Statistics, Australia)*; Johanna M Geleijnse
(Wageningen University, The Netherlands)*; Anoosheh Ghasemian (Non-Communicable Diseases
Research Center, Iran)*; Simona Giampaoli (Istituto Superiore di Sanita`, Italy)*; Francesco Gianfagna
(University of Insubria, Italy)*; Jonathan Giovannelli (Lille University Hospital, France)*; Aleksander
Giwercman (Lund University, Sweden)*; Rebecca A Goldsmith (Nutrition Department, Ministry of
Health, Israel)*; Helen Gonc¸alves (Federal University of Pelotas, Brazil)*; Marcela Gonzalez Gross
(Universidad Polite´cnica de Madrid, Spain)*; Juan P Gonza´lez Rivas (The Andes Clinic of Cardio-Met-
abolic Studies, Venezuela)*; Mariano Bonet Gorbea (National Institute of Hygiene, Epidemiology
and Microbiology, Cuba)*; Frederic Gottrand (Universite´ de Lille 2, France)*; Sidsel Graff-Iversen
(Norwegian Institute of Public Health, Norway)*; Dusˇan Grafnetter (Institute for Clinical and Experi-
mental Medicine, Czech Republic)*; Aneta Grajda (Children’s Memorial Health Institute, Poland)*;
Maria G Grammatikopoulou (Alexander Technological Educational Institute, Greece)*; Ronald D Gre-
gor (Dalhousie University, Canada)*; Tomasz Grodzicki (Jagiellonian University Medical College,
Poland)*; Anders Grøntved (University of Southern Denmark, Denmark)*; Grabriella Gruden (Univer-
sity of Turin, Italy)*; Vera Grujic (University of Novi Sad, Serbia)*; Dongfeng Gu (National Center of
Cardiovascular Diseases, China)*; Emanuela Gualdi-Russo (University of Ferrara, Italy)*; Ong Peng
Guan (Singapore Eye Research Institute, Singapore)*; Vilmundur Gudnason (Icelandic Heart Associa-
tion, Iceland)*; Ramiro Guerrero (Universidad Icesi, Colombia)*; Idris Guessous (Geneva University
Hospitals, Switzerland)*; Andre L Guimaraes (State University of Montes Claros, Brazil)*; Martin C
Gulliford (King’s College London, UK)*; Johanna Gunnlaugsdottir (Icelandic Heart Association, Ice-
land)*; Marc Gunter (Imperial College London, UK)*; Xiuhua Guo (Capital Medical University, China)
*; Yin Guo (Capital Medical University, China)*; Prakash C Gupta (Healis - Sekhsaria Institute for Pub-
lic Health, India)*; Oye Gureje (University of Ibadan, Nigeria)*; Beata Gurzkowska (Children’s Memo-
rial Health Institute, Poland)*; Laura Gutierrez (Institute for Clinical Effectiveness and Health Policy,
Argentina)*; Felix Gutzwiller (University of Zurich, Switzerland)*; Jytte Halkjær (Danish Cancer Society
Research Centre, Denmark)*; Ian R Hambleton (The University of the West Indies, Barbados)*;
Rebecca Hardy (University College London, UK)*; Rachakulla Hari Kumar (Indian Council of Medical
Research, India)*; Jun Hata (Kyushu University, Japan)*; Alison J Hayes (University of Sydney, Aus-
tralia)*; Jiang He (Tulane University, USA)*; Marleen Elisabeth Hendriks (Academic Medical Center of
University of Amsterdam, The Netherlands)*; Leticia Hernandez Cadena (National Institute of Public
Health, Mexico)*; Sauli Herrala (Oulu University Hospital, Finland)*; Ramin Heshmat (Chronic Dis-
eases Research Center, Iran)*; Ilpo Tapani Hihtaniemi (Imperial College London, UK)*; Sai Yin Ho
(University of Hong Kong, China), Suzanne C Ho (The Chinese University of Hong Kong, China)*;
Michael Hobbs (University of Western Australia, Australia)*; Albert Hofman (Erasmus Medical Center
Rotterdam, The Netherlands)*; Claudia M Hormiga (Fundacio´n Oftalmolo´gica de Santander, Colom-
bia)*; Bernardo L Horta (Universidade Federal de Pelotas, Brazil)*; Leila Houti (University of Oran 1,
Algeria)*; Christina Howitt (The University of the West Indies, Barbados)*; Thein Thein Htay (Inde-
pendent Public Health Specialist, Myanmar)*; Aung Soe Htet (University of Oslo, Norway)*; Maung
Maung Than Htike (International Realtions Division, Nay Pyi Taw)*; Yonghua Hu (Peking University
Health Science Center, China)*; Abdullatif Husseini (Birzeit University, Palestine)*; Chinh Nguyen Huu
(National Institute of Nutrition, Vietnam)*; Inge Huybrechts (International Agency for Research on
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Cancer, France)*; Nahla Hwalla (American University of Beirut, Lebanon)*; Licia Iacoviello (IRCCS Isti-
tuto Neurologico Mediterraneo Neuromed, Italy)*; Anna G Iannone (Cardiologia di Mercato S.
Severino, Italy)*; Mohsen M Ibrahim (Cairo University, Egypt)*; Nayu Ikeda (National Institute of
Health and Nutrition, Japan)*; M Arfan Ikram (Erasmus Medical Center Rotterdam, The Netherlands)
*; Vilma E Irazola (Institute for Clinical Effectiveness and Health Policy, Argentina)*; Muhammad Islam
(Aga Khan University, Pakistan)*; Vanja Ivkovic (UHC Zagreb, Croatia)*; Masanori Iwasaki (Niigata
University, Japan)*; Rod T Jackson (University of Auckland, New Zealand)*; Jeremy M Jacobs (Hadas-
sah University Medical Center, Israel)*; Tazeen Jafar (Duke-NUS Graduate Medical School, Singa-
pore)*; Kazi M Jamil (Kuwait Institute for Scientific Research, Kuwait)*; Konrad Jamrozik (University
of Adelaide, Australia; deceased)*; Imre Janszky (Norwegian University of Science and Technology,
Norway)*; Grazyna Jasienska (Jagiellonian University Medical College, Poland)*; Bojan Jelakovic
(University of Zagreb School of Medicine, Croatia)*; Chao Qiang Jiang (Guangzhou 12th Hospital,
China)*; Michel Joffres (Simon Fraser University, Canada)*; Mattias Johansson (International Agency
for Research on Cancer, France)*; Jost B Jonas (Ruprecht-Karls-University of Heidelberg, Germany)*;
Torben Jørgensen (Research Centre for Prevention and Health, Denmark)*; Pradeep Joshi (World
Health Organization Country Office, India)*; Anne Juolevi (National Institute for Health and Welfare,
Finland)*; Gregor Jurak (University of Ljubljana, Slovenia)*; Vesna Juresˇa (University of Zagreb, Cro-
atia)*; Rudolf Kaaks (German Cancer Research Center, Germany)*; Anthony Kafatos (University of
Crete, Greece)*; Ofra Kalter-Leibovici (The Gertner Institute for Epidemiology and Health Policy
Research, Israel)*; Efthymios Kapantais (Hellenic Medical Association for Obesity, Greece)*; Amir
Kasaeian (Tehran University of Medical Science, Iran)*; Joanne Katz (Johns Hopkins Bloomberg
School of Public Health, USA)*; Prabhdeep Kaur (National Institute of Epidemiology, India)*; Maryam
Kavousi (Erasmus Medical Center Rotterdam, The Netherlands)*; Ulrich Keil (University of Mu¨nster,
Germany)*; Lital Keinan Boker ( Israel Center for Disease Control, Israel)*; Sirkka Keina¨nen-Kiukaan-
niemi (Oulu University Hospital, Finland)*; Roya Kelishadi (Research Institute for Primordial Preven-
tion of Non Communicable Disease, Iran)*; Han CG Kemper (VU University Medical Center, The
Netherlands)*; Andre P Kengne (South African Medical Research Council, South Africa)*; Mathilde
Kersting (Research Institute of Child Nutrition, Germany)*; Timothy Key (University of Oxford, UK)*;
Yousef Saleh Khader (Jordan University of Science and Technology, Jordan)*; Davood Khalili (Shahid
Beheshti University of Medical Sciences, Iran)*; Young-Ho Khang (Seoul National University, South
Korea)*; Kay-Tee H Khaw (University of Cambridge, UK)*; Ilse MSL Khouw (FrieslandCampina, Singa-
pore)*; Stefan Kiechl (Medical University Innsbruck, Austria)*; Japhet Killewo (Muhimbili University of
Health and Allied Sciences, Tanzania)*; Jeongseon Kim (National Cancer Center, South Korea), Jean-
nette Klimont (Statistics Austria, Austria)*; Jurate Klumbiene (Lithuanian University of Health Scien-
ces, Lithuania)*; Bhawesh Koirala (B P Koirala Institute of Health Sciences, Nepal)*; Elin Kolle
(Norwegian School of Sport Sciences, Norway)*; Patrick Kolsteren (Institute of Tropical Medicine,
Belgium)*; Paul Korrovits (Tartu University Clinics, Estonia)*; Seppo Koskinen (National Institute for
Health and Welfare, Finland)*; Katsuyasu Kouda (Kindai University Faculty of Medicine, Japan)*; Sla-
womir Koziel (Polish Academy of Sciences Anthropology Unit in Wroclaw, Poland)*; Wolfgang Krat-
zer (University Hospital Ulm, Germany)*; Steinar Krokstad (Norwegian University of Science and
Technology, Norway)*; Daan Kromhout (Wageningen University, The Netherlands)*; Herculina S
Kruger (North-West University, South Africa)*; Ruzena Kubinova (National Institute of Public Health,
Czech Republic)*; Urho M Kujala (University of Jyva¨skyla¨, Finland)*; Krzysztof Kula (Medical University
of Lodz, Poland)*; Zbigniew Kulaga (The Children’s Memorial Health Institute, Poland)*; R Krishna
Kumar (Amrita Institute of Medical Sciences, India)*; Pawel Kurjata (The Cardinal Wyszynski Institute
of Cardiology, Poland)*; Yadlapalli S Kusuma (All India Institute of Medical Sciences, India)*; Kari
Kuulasmaa (National Institute for Health and Welfare, Finland)*; Catherine Kyobutungi (African Popu-
lation and Health Research Center, Kenya)*; Fatima Zahra Laamiri (Higher Institute of Nursing Profes-
sions and Technical Health, Morocco)*; Tiina Laatikainen (National Institute for Health and Welfare,
Finland)*; Carl Lachat (Ghent University, Belgium)*; Youcef Laid (National Institute of Public Health
of Algeria, Algeria)*; Tai Hing Lam (University of Hong Kong, China)*; Orlando Landrove (Ministerio
de Salud Pu´blica, Cuba)*; Vera Lanska (Institute for Clinical and Experimental Medicine, Czech
Republic)*; Georg Lappas (Sahlgrenska Academy, Sweden)*; Bagher Larijani (Endocrinology and
Metabolism Research Center, Iran)*; Lars E Laugsand (Norwegian University of Science and Technol-
ogy, Norway)*; Avula Laxmaiah (Indian Council of Medical Research, India)*; Khanh Le Nguyen Bao
(National Institute of Nutrition, Vietnam)*; Tuyen D Le (National Institute of Nutrition, Vietnam)*;
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Catherine Leclercq (Food and Agriculture Organization, Italy)*; Jeannette Lee (National University of
Singapore, Singapore)*; Jeonghee Lee (National Cancer Center, South Korea)*; Terho Lehtima¨ki
(Tampere University Hospital, Finland)*; Rampal Lekhraj (Universiti Putra Malaysia, Malaysia)*; Luz M
Leo´n-Mun˜oz (Universidad Auto´noma de Madrid, Spain)*; Yanping Li (Harvard TH Chan School of
Public Health, USA)*; Christa L Lilly (West Virginia University, USA)*; Wei-Yen Lim (National Univer-
sity of Singapore, Singapore)*; M Fernanda Lima-Costa (Oswaldo Cruz Foundation Rene Rachou
Research Institute, Brazil)*; Hsien-Ho Lin (National Taiwan University, Taiwan)*; Xu Lin (University of
Chinese Academy of Sciences, China)*; Allan Linneberg (Research Centre for Prevention and Health,
Denmark)*; Lauren Lissner (University of Gothenburg, Sweden)*; Mieczyslaw Litwin (The Children’s
Memorial Health Institute, Poland)*; Jing Liu (Beijing Anzhen Hospital, Capital Medical University,
China)*; Roberto Lorbeer (University Medicine Greifswald, Germany)*; Paulo A Lotufo (University of
Sa˜o Paulo, Brazil)*; Jose´ Eugenio Lozano (Consejerı´a de Sanidad Junta de Castilla y Leo´n, Spain)*;
Dalia Luksiene (Lithuanian University of Health Sciences, Lithuania)*; Annamari Lundqvist (National
Institute for Health and Welfare, Finland)*; Nuno Lunet (Universidade do Porto, Portugal)*; Per Lytsy
(University of Uppsala, Sweden)*; Guansheng Ma (Peking University, China)*; Jun Ma (Peking Univer-
sity, China)*; George LL Machado-Coelho (Universidade Federal de Ouro Preto, Brazil)*; Suka Machi
(The Jikei University School of Medicine, Japan)*; Stefania Maggi (National Research Council, Italy)*;
Dianna J Magliano (Baker IDI Heart and Diabetes Institute, Australia)*; Bernard Maire (Institut de
Recherche pour le De´veloppement, France)*; Marcia Makdisse (Hospital Israelita Albert Einstein,
Brazil)*; Reza Malekzadeh (Tehran University of Medical Sciences, Iran)*; Rahul Malhotra (Duke-NUS
Graduate Medical School, Singapore)*; Kodavanti Mallikharjuna Rao (Indian Council of Medical
Research, India)*; Sofia Malyutina (Institute of Internal and Preventive Medicine, Russia)*; Yannis
Manios (Harokopio University, Greece)*; Jim I Mann (University of Otago, New Zealand)*; Enzo Man-
zato (University of Padova, Italy)*; Paula Margozzini (Pontificia Universidad Cato´lica de Chile, Chile)*;
Oonagh Markey (University of Reading, UK)*; Pedro Marques-Vidal (Lausanne University Hospital,
Switzerland)*; Jaume Marrugat (Institut Hospital del Mar d’Investigacions Me`diques, Spain)*; Yves
Martin-Prevel (Institut de Recherche pour le De´veloppement, France)*; Reynaldo Martorell (Emory
University, USA)*; Shariq R Masoodi (Sher-i-Kashmir Institute of Medical Sciences, India)*; Ellisiv B
Mathiesen (UiT The Arctic University of Norway, Norway)*; Tandi E Matsha (Cape Peninsula Univer-
sity of Technology, South Africa)*; Artur Mazur (University of Rzeszow, Poland)*; Jean Claude N
Mbanya (University of Yaounde´ 1, Cameroon)*; Shelly R McFarlane (The University of the West
Indies, Jamaica)*; Stephen T McGarvey (Brown University, USA)*; Martin McKee (London School of
Hygiene & Tropical Medicine, UK)*; Stela McLachlan (University of Edinburgh, UK)*; Rachael M
McLean (University of Otago, New Zealand)*; Breige A McNulty (University College Dublin, Ireland)
*; Safiah Md Yusof (Universiti Teknologi MARA, Malaysia)*; Sounnia Mediene-Benchekor (University
of Oran 1, Algeria)*; Aline Meirhaeghe (Institut National de la Sante´ et de la Recherche Me´dicale,
France)*; Christa Meisinger (Helmholtz Zentrum Mu¨nchen, Germany)*; Ana Maria B Menezes (Univer-
sidade Federal de Pelotas, Brazil)*; Gert BM Mensink (Robert Koch Institute, Germany)*; Indrapal I
Meshram (Indian Council of Medical Research, India)*; Andres Metspalu (University of Tartu, Estonia)
*; Jie Mi (Capital Institute of Pediatrics, China)*; Kim F Michaelsen (University of Copenhagen, Den-
mark)*; Kairit Mikkel (University of Tartu, Estonia)*; Jody C Miller (University of Otago, New Zealand)
*; Juan Francisco Miquel (Pontificia Universidad Cato´lica de Chile, Chile)*; J Jaime Miranda (Universi-
dad Peruana Cayetano Heredia, Peru)*; Marjeta Misˇigoj-Durakovic (University of Zagreb, Croatia)*;
Mostafa K Mohamed (Ain Shams University, Egypt)*; Kazem Mohammad (Tehran University of Medi-
cal Sciences, Iran)*; Noushin Mohammadifard (Isfahan Cardiovascular Research Center, Iran)*; Viswa-
nathan Mohan (Madras Diabetes Research Foundation, India)*; Muhammad Fadhli Mohd Yusoff
(Ministry of Health Malaysia, Malaysia)*; Drude Molbo (University of Copenhagen, Denmark)*; Niels
C Møller (University of Southern Denmark, Denmark)*; De´nes Molna´r (University of Pe´cs, Hungary)*;
Charles K Mondo (Mulago Hospital, Uganda)*; Eric A Monterrubio (Instituto Nacional de Salud Pu´b-
lica, Mexico)*; Kotsedi Daniel K Monyeki (University of Limpopo, South Africa)*; Leila B Moreira (Uni-
versidade Federal do Rio Grande do Sul, Brazil)*; Alain Morejon (University Medical Science, Cuba)*;
Luis A Moreno (Universidad de Zaragoza, Spain)*; Karen Morgan (RCSI Dublin, Ireland)*; Erik Lykke
Mortensen (University of Copenhagen, Denmark)*; George Moschonis (Harokopio University,
Greece)*; Malgorzata Mossakowska (International Institute of Molecular and Cell Biology, Poland)*;
Aya Mostafa (Ain Shams University, Egypt)*; Jorge Mota (University of Porto, Portugal)*; Mohammad
Esmaeel Motlagh (Ahvaz Jundishapur University of Medical Sciences, Iran)*; Jorge Motta (Gorgas
NCD Risk Factor Collaboration (NCD-RisC). eLife 2016;5:e13410. DOI: 10.7554/eLife.13410 21 of 29
Research article Epidemiology and Global Health
Memorial Institute of Public Health, Panama)*; Thet Thet Mu (Department of Public Health, Myan-
mar)*; Maria Lorenza Muiesan (University of Brescia, Italy)*; Martina Mu¨ller-Nurasyid (Helmholtz Zen-
trum Mu¨nchen, Germany)*; Neil Murphy (Imperial College London, UK)*; Jaakko Mursu (University of
Eastern Finland, Finland)*; Elaine M Murtagh (Mary Immaculate College, Ireland)*; Kamarul Imran
Musa (Universiti Sains Malaysia, Kota Bharu, Malaysia)*; Vera Musil (University of Zagreb, Croatia)*;
Gabriele Nagel (Ulm University, Germany)*; Harunobu Nakamura (Kobe University, Japan)*; Jana
Na´mesˇna´ (Regional Authority of Public Health, Banska Bystrica, Slovakia)*; Ei Ei K Nang (National
University of Singapore, Singapore)*; Vinay B Nangia (Suraj Eye Institute, India)*; Martin Nankap
(Helen Keller International, Cameroon)*; Sameer Narake (Healis - Sekhsaria Institute for Public
Health, India)*; Eva Maria Navarrete-Mun˜oz (CIBER en Epidemiologı´a y Salud Pu´blica, Spain)*; Wil-
liam A Neal (West Virginia University, USA)*; Ilona Nenko (Jagiellonian University Medical College,
Poland)*; Martin Neovius (Karolinska Institutet, Sweden)*; Flavio Nervi (Pontificia Universidad Cato´l-
ica de Chile, Chile)*; Hannelore K Neuhauser (Robert Koch Institute, Germany)*; Nguyen D Nguyen
(University of Pharmacy and Medicine of Ho Chi Minh City, Vietnam)*; Quang Ngoc Nguyen (Hanoi
Medical University, Vietnam)*; Ramfis E Nieto-Martı´nez (Universidad Centro-Occidental Lisandro
Alvarado, Venezuela)*; Guang Ning (Shanghai Jiao-Tong University School of Medicine, China)*;
Toshiharu Ninomiya (Kyushu University, Japan)*; Sania Nishtar (Heartfile, Pakistan)*; Marianna Noale
(National Research Council, Italy)*; Teresa Norat (Imperial College London, UK)*; Davide Noto (Uni-
versity of Palermo, Italy)*; Mohannad Al Nsour (Eastern Mediterranean Public Health Network, Jor-
dan)*; Dermot O’Reilly (The Queen’s University of Belfast, UK)*; Kyungwon Oh (Korea Centers for
Disease Control and Prevention, South Korea)*; Iman H Olayan (Kuwait Institute for Scientific
Research, Kuwait)*; Maria Teresa Anselmo Olinto (University of Vale do Rio dos Sinos, Brazil)*;
Maciej Oltarzewski (National Food and Nutrition Institute, Poland), Mohd A Omar (Ministry of Health
Malaysia, Malaysia)*; Altan Onat (Istanbul University, Turkey)*; Pedro Ordunez (Pan American Health
Organization, USA)*; Ana P Ortiz (University of Puerto Rico, Puerto Rico)*; Merete Osler (Research
Center for Prevention and Health, Denmark)*; Clive Osmond (MRC Lifecourse Epidemiology Unit,
UK)*; Sergej M Ostojic (University of Novi Sad, Serbia)*; Johanna A Otero (Fundacio´n Oftalmolo´gica
de Santander, Colombia)*; Kim Overvad (Aarhus University, Denmark)*; Ellis Owusu-Dabo (Kwame
Nkrumah University of Science and Technology, Ghana)*; Fred Michel Paccaud (Institute for Social
and Preventive Medicine, Switzerland)*; Cristina Padez (University of Coimbra, Portugal)*; Elena
Pahomova (University of Latvia, Latvia)*; Andrzej Pajak (Jagiellonian University Medical College,
Poland)*; Domenico Palli (Cancer Prevention and Research Institute, Italy)*; Alberto Palloni (Univer-
sity of Wisconsin-Madison, USA)*; Luigi Palmieri (Istituto Superiore di Sanita`, Italy)*; Songhomitra
Panda-Jonas (Ruprecht-Karls-University of Heidelberg, Germany)*; Francesco Panza (University of
Bari, Italy)*; Winsome R Parnell (University of Otago, New Zealand)*; Mahboubeh Parsaeian (Tehran
University of Medical Sciences, Iran)*; Ivan Pecin (University of Zagreb, Croatia)*; Mangesh S Pedne-
kar (Healis - Sekhsaria Institute for Public Health, India)*; Petra H Peeters (University Medical Center
Utrecht, The Netherlands)*; Sergio Viana Peixoto (Oswaldo Cruz Foundation Rene Rachou Research
Institute, Brazil)*; Markku Peltonen (National Institute for Health and Welfare, Finland)*; Alexandre C
Pereira (Heart Institute, Brazil)*; Cynthia M Pe´rez (University of Puerto Rico, Puerto Rico)*; Annette
Peters (Helmholtz Zentrum Mu¨nchen, Germany)*; Janina Petkeviciene (Lithuanian University of
Health Sciences, Lithuania)*; Niloofar Peykari (Non-Communicable Diseases Research Center, Iran)*;
Son Thai Pham (Vietnam National Heart Institute, Vietnam)*; Iris Pigeot (Leibniz Institute for Preven-
tion Research and Epidemiology - BIPS, Germany)*; Hynek Pikhart (University College London, UK)*;
Aida Pilav (Federal Ministry of Health, Bosnia and Herzegovina)*; Lorenza Pilotto (Cardiovascular
Prevention Centre, Italy)*; Francesco Pistelli (University Hospital of Pisa, Italy)*; Freda Pitakaka (Uni-
versity of New South Wales, Australia)*; Aleksandra Piwonska (The Cardinal Wyszynski Institute of
Cardiology, Poland)*; Pedro Plans-Rubio´ (Public Health Agency of Catalonia, Spain)*; Bee Koon Poh
(Universiti Kebangsaan Malaysia, Malaysia)*; Miquel Porta (Institut Hospital del Mar d’Investigacions
Me`diques, Spain)*; Marileen LP Portegies (Erasmus Medical Center Rotterdam, The Netherlands)*;
Dimitrios Poulimeneas (Alexander Technological Educational Institute, Greece)*; Rajendra Pradeepa
(Madras Diabetes Research Foundation, India)*; Mathur Prashant (Indian Council of Medical
Research, India)*; Jacqueline F Price (University of Edinburgh, UK)*; Maria Puiu (Victor Babes Univer-
sity of Medicine and Pharmacy Timisoara, Romania)*; Margus Punab (Tartu University Clinics, Esto-
nia), Radwan F Qasrawi (Al-Quds University, Palestine)*; Mostafa Qorbani (Alborz University of
Medical Sciences, Iran)*; Tran Quoc Bao (Ministry of Health, Vietnam)*; Ivana Radic (University of
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Novi Sad, Serbia)*; Ricardas Radisauskas (Lithuanian University of Health Sciences, Lithuania)*; Mah-
mudur Rahman (Institute of Epidemiology Disease Control and Research, Bangladesh)*; Olli Raitakari
(Turku University Hospital, Finland)*; Manu Raj (Amrita Institute of Medical Sciences, India)*; Sudha
Ramachandra Rao (National Institute of Epidemiology, India)*; Ambady Ramachandran (India Diabe-
tes Research Foundation, India)*; Jacqueline Ramke (University of New South Wales, Australia)*;
Rafel Ramos (Institut Universitari d’Investigacio´ en Atencio´ Prima`ria Jordi Gol, Spain)*; Sanjay Ram-
pal (University of Malaya, Malaysia)*; Finn Rasmussen (Karolinska Institutet, Sweden)*; Josep Redon
(University of Valencia, Spain)*; Paul Ferdinand M Reganit (University of the Philippines, Philippines)
*; Robespierre Ribeiro (Minas Gerais State Secretariat for Health, Brazil)*; Elio Riboli (Imperial Col-
lege London, UK)*; Fernando Rigo (Health Center San Agustı´n, Spain)*; Tobias F Rinke de Wit (Phar-
mAccess Foundation, The Netherlands)*; Raphael M Ritti-Dias (Hospital Israelita Albert Einstein,
Brazil)*; Juan A Rivera (Instituto Nacional de Salud Pu´blica, Mexico)*; Sian M Robinson (University of
Southampton, UK)*; Cynthia Robitaille (Public Health Agency of Canada, Canada)*; Fernando Rodrı´-
guez-Artalejo (Universidad Auto´noma de Madrid, Spain)*; Marı´a del Cristo Rodriguez-Perez (Canar-
ian Health Service, Spain)*; Laura A Rodrı´guez-Villamizar (Universidad Industrial de Santander,
Colombia)*; Rosalba Rojas-Martinez (Instituto Nacional de Salud Pu´blica, Mexico)*; Nipa Rojroong-
wasinkul (Mahidol University, Thailand)*; Dora Romaguera (CIBEROBN, Spain)*; Kimmo Ronkainen
(University of Eastern Finland, Finland)*; Annika Rosengren (University of Gothenburg, Sweden)*; Ian
Rouse (Fiji National University, Fiji)*; Adolfo Rubinstein (Institute for Clinical Effectiveness and Health
Policy, Argentina)*; Frank J Ru¨hli (University of Zurich, Switzerland)*; Ornelas Rui (University of
Madeira, Portugal)*; Blanca Sandra Ruiz-Betancourt (Instituto Mexicano del Seguro Social, Mexico)*;
Andrea RV Russo Horimoto (Heart Institute, Brazil)*; Marcin Rutkowski (Medical University of Gdansk,
Poland)*; Charumathi Sabanayagam (Singapore Eye Research Institute, Singapore)*; Harshpal S
Sachdev (Sitaram Bhartia Institute of Science and Research, India)*; Olfa Saidi (Faculty of medicine of
Tunis, Tunisia)*; Benoit Salanave (French Public Health Agency, France)*; Eduardo Salazar Martinez
(National Institute of Public Health, Mexico)*; Veikko Salomaa (National Institute for Health and Wel-
fare, Finland)*; Jukka T Salonen (University of Helsinki, Finland)*; Massimo Salvetti (University of
Brescia, Italy)*; Jose Sa´nchez-Abanto (National Institute of Health, Peru)*; Sandjaja (Ministry of
Health, Indonesia); Susana Sans (Catalan Department of Health, Spain)*; Diana A Santos (Universi-
dade de Lisboa, Portugal)*; Osvaldo Santos (Institute of Preventive Medicine and Public Health, Por-
tugal)*; Renata Nunes dos Santos (University of Sao Paulo Clinics Hospital, Brazil)*; Rute Santos
(University of Porto, Portugal)*; Jouko L Saramies (South Karelia Social and Health Care District, Fin-
land)*; Luis B Sardinha (Universidade de Lisboa, Portugal)*; Nizal Sarrafzadegan (Isfahan Cardiovas-
cular Research Center, Iran)*; Kai-Uwe Saum (German Cancer Research Center, Germany)*; Savvas C
Savva (Research and Education Institute of Child Health, Cyprus)*; Marcia Scazufca (University of Sao
Paulo Clinics Hospital, Brazil)*; Angelika Schaffrath Rosario (Robert Koch Institute, Germany)*; Her-
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